首页|期刊导航|中国医学前沿杂志(电子版)|临床试验方案规范指南与临床试验报告统一标准的应用与发展

临床试验方案规范指南与临床试验报告统一标准的应用与发展OA

Application and development of the SPIRIT and CONSORT guidelines

中文摘要英文摘要

随机对照试验作为评估干预措施疗效的"金标准",其研究质量取决于严谨的设计与实施.然而,当前许多随机对照试验存在诸多问题,例如关键信息缺失、方案与结果报告不一致、选择性报告以及结果无法复现等,这些问题严重影响了研究的质量和可信度.在此背景下,临床试验方案规范指南(standard protocol items:Recommendations for interven-tional trials,SPIRIT)和临床试验报告统一标准(consolidated standards of reporting trials,CONSORT)应运而生,成为了保障临床试验质量的重要工具.遵循SPIRIT/CONSORT的完整透明报告,有助于提升研究结果的可验证性,并减少选择性报告偏倚.2025年4月,SPIRIT 2025和CONSORT 2025同步更新,旨在确保临床试验从方案设计到结果报告的全周期透明度和完整性,从而协同提升临床试验的整体质量.然而,这两项指南在实际应用中仍面临诸多挑战.本文对近20年来SPIRIT与CONSORT的历史发展及其2025更新版指南进行总结与讨论,旨在为其临床应用提供参考.

Randomized controlled trials(RCTs),recognized as the"gold standard"for evaluating intervention efficacy,and the quality of an RCT depends on its rigorous design and implementation.However,many current RCTs suffer from various problems,such as missing key information,inconsistencies between protocol and results reporting,selective reporting,and irreproducible results.These issues seriously affect the quality and credibility of the studies.Against this backdrop,the standard protocol items:Recommendations for interventional trials(SPIRIT)and the consolidated standards of reporting trials(CONSORT)have emerged as essential frameworks for clinical trial quality assurance.Following the complete and transparent reporting in accordance with CONSORT/SPIRIT guidelines helps enhance the verifiability of research results and reduces the bias of selective reporting.In April 2025,the SPIRIT 2025 and CONSORT 2025 guidelines were updated simultaneously to ensure full-cycle transparency and integrity,from protocol design to results reporting,thereby jointly improving the overall quality of clinical trials.Nevertheless,the practical application of these guidelines encounters many challenges.This review synthesizes the historical development of the SPIRIT and CONSORT guidelines over the past two decades and details their latest iterations,aiming to provide references for their clinical application.

李志强;刘建平

北京中医药大学循证医学中心,北京 100029北京中医药大学循证医学中心,北京 100029

临床试验报告统一标准临床试验方案规范指南报告清单研究进展

CONSORTSPIRITReporting checklistsStudy progress

《中国医学前沿杂志(电子版)》 2026 (1)

25-31,7

国家中医药管理局高水平中医药重点学科建设项目—中医药循证医学(zyyzdxk-2023249) The High-level Traditional Chinese Medicine Key Subject Construction Project of National Administration of Traditional Chinese Medicine-Evidence-based Traditional Chinese Medicine(zyyzdxk-2023249)

10.12037/YXQY.2026.01-04

评论